Article
The validity of giving adjuvant capecitabine after standard anthracycline and/or taxanes based neo-/adjuvant chemotherapy in early triple-negative breast cancer patients: An Egypt
Last updated: 07 Jan 2025
Article
Article
Article
Article
Article
Article
Article
Article
Article
Article